Abstract

For various groups of tumors, clinical characteristics are discussed which are important with respect to responses to fractionated treatments with supervoltage X-rays and with respect to problems to be expected with fast neutron treatments. Physical characteristics of supervoltage X-ray beams, with small penumbra, skin sparing and large depth dose, provde important advantages which are unlikely to be equalled by fast neutron beams. As a consequence the usefulness of fast neutrons might be limited in cases where either a critical structure is near the tumor bearing volume or where large areas of skin receive doses equal to the tumor dose. Different groups of tumors are distinguished which currently are highly curable or are not suitable for neutron treatment for other reasons, whereas others are discussed which seem to be candidates for neutron therapy, although methods are not available to predict their responses.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.